The impact of social network dynamics on engagement in drug use reduction programs among men and women who use drugs.


Journal

Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909

Informations de publication

Date de publication:
06 2022
Historique:
received: 19 07 2021
revised: 02 11 2021
accepted: 14 12 2021
pubmed: 1 1 2022
medline: 12 5 2022
entrez: 31 12 2021
Statut: ppublish

Résumé

Cross-sectional studies have shown strong relationships between social network characteristics and substance use disorder (SUD) treatment engagement. The current study examined associations between longitudinal changes in egocentric social networks of male and female people who use drugs (PWUD) and engagement in drug use reduction programs, broadly defined as either formal SUD treatment or self-help groups. Using data from an HIV prevention and care study in Baltimore, MD, this study categorized PWUD into those who engaged and did not engage in any drug use reduction programs over two follow-ups during a one-year observation window. The study used multivariate logistic generalized estimating equations (GEE) to examine associations between network composition and stability measures and drug use reduction program engagement, stratified by gender. Of the 176 subjects participating in drug use reduction programs at baseline, 56.3% remained engaged at one year. Among both male and female respondents, higher turnover into non-kin networks was associated with increased odds of engagement in drug use reduction programs (AOR 1.4; 95% CI: 1.1-1.9, AOR 1.3; 95% CI: 1.0-1.8, respectively). For males, retention of intimate partner networks was associated with increased odds of program engagement (AOR 2.9; 95% CI: 1.1-7.6); for females, higher turnover into kin networks was associated with decreased odds of engagement (AOR 0.8; 95% CI: 0.5-1.0). Evaluation of associations between social network characteristics and drug use reduction program engagement appears to benefit from longitudinal analyses that are stratified by gender. Efforts to improve retention in formal SUD treatment or self-help groups might consider intervening through social networks, perhaps by increasing overall levels of social support.

Sections du résumé

BACKGROUND
Cross-sectional studies have shown strong relationships between social network characteristics and substance use disorder (SUD) treatment engagement. The current study examined associations between longitudinal changes in egocentric social networks of male and female people who use drugs (PWUD) and engagement in drug use reduction programs, broadly defined as either formal SUD treatment or self-help groups.
METHOD
Using data from an HIV prevention and care study in Baltimore, MD, this study categorized PWUD into those who engaged and did not engage in any drug use reduction programs over two follow-ups during a one-year observation window. The study used multivariate logistic generalized estimating equations (GEE) to examine associations between network composition and stability measures and drug use reduction program engagement, stratified by gender.
RESULTS
Of the 176 subjects participating in drug use reduction programs at baseline, 56.3% remained engaged at one year. Among both male and female respondents, higher turnover into non-kin networks was associated with increased odds of engagement in drug use reduction programs (AOR 1.4; 95% CI: 1.1-1.9, AOR 1.3; 95% CI: 1.0-1.8, respectively). For males, retention of intimate partner networks was associated with increased odds of program engagement (AOR 2.9; 95% CI: 1.1-7.6); for females, higher turnover into kin networks was associated with decreased odds of engagement (AOR 0.8; 95% CI: 0.5-1.0).
CONCLUSION
Evaluation of associations between social network characteristics and drug use reduction program engagement appears to benefit from longitudinal analyses that are stratified by gender. Efforts to improve retention in formal SUD treatment or self-help groups might consider intervening through social networks, perhaps by increasing overall levels of social support.

Identifiants

pubmed: 34969578
pii: S0740-5472(21)00439-6
doi: 10.1016/j.jsat.2021.108713
pmc: PMC9086095
mid: NIHMS1767491
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

108713

Subventions

Organisme : NIDA NIH HHS
ID : K23 DA041294
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA040488
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Harm Reduct J. 2020 Oct 19;17(1):78
pubmed: 33076931
Cell Transplant. 2019 Dec;28(12):1465-1471
pubmed: 31547679
J Stud Alcohol. 2005 Jul;66(4):497-505
pubmed: 16240557
Clin Psychol Rev. 2008 Jul;28(6):952-62
pubmed: 18374464
Am J Addict. 2002 Winter;11(1):24-40
pubmed: 11876581
J Youth Adolesc. 1991 Apr;20(2):149-66
pubmed: 24265004
Am J Addict. 2008 Sep-Oct;17(5):414-21
pubmed: 18770085
Cult Health Sex. 2017 Nov;19(11):1239-1253
pubmed: 28398134
Drug Alcohol Depend. 1997 Jun 6;46(1-2):41-51
pubmed: 9246552
Subst Use Misuse. 2013 Jan;48(1-2):181-91
pubmed: 23368704
J Health Psychol. 2008 Apr;13(3):388-400
pubmed: 18420772
Am J Addict. 2013 Jan;22(1):18-22
pubmed: 23398222
Drug Alcohol Depend. 2013 Nov 1;133(1):146-53
pubmed: 23791039
Drug Alcohol Depend. 2018 Jul 1;188:161-168
pubmed: 29778009
Drug Alcohol Depend. 2005 Feb 14;77(2):177-84
pubmed: 15664719
AIDS Behav. 2019 Jan;23(1):201-210
pubmed: 30218319
Lancet. 2019 Jun 15;393(10189):2440-2454
pubmed: 31155275
Addict Behav. 2003 Jan-Feb;28(1):141-55
pubmed: 12507533
J Subst Abuse Treat. 2001 Jan;20(1):53-7
pubmed: 11239728
Psychiatr Serv. 2018 Jul 1;69(7):768-776
pubmed: 29656707
J Subst Abuse Treat. 2003 Oct;25(3):177-86
pubmed: 14670523
Curr Opin HIV AIDS. 2014 Mar;9(2):150-5
pubmed: 24406532
Drug Alcohol Depend. 2008 Oct 1;97(3):226-30
pubmed: 18499355
Drug Alcohol Depend. 2001 Dec 1;65(1):65-75
pubmed: 11714591
Psychiatr Serv. 2004 Jul;55(7):767-74
pubmed: 15232015
J Subst Abuse Treat. 2002 Dec;23(4):387-97
pubmed: 12495801
J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S176-81
pubmed: 25978485
Addiction. 2006 Jul;101(7):1003-13
pubmed: 16771892
NIDA Res Monogr. 1995;151:20-37
pubmed: 8742759
J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S155-61
pubmed: 25978482
Psychiatr Serv. 1996 Jul;47(7):709-13
pubmed: 8807683
J Subst Abuse Treat. 2018 Feb;85:90-96
pubmed: 28733097
Community Ment Health J. 2015 Jul;51(5):621-7
pubmed: 25563485
Drug Alcohol Depend. 2013 Feb 1;128(1-2):123-9
pubmed: 22999417
AIDS Behav. 2018 Nov;22(11):3500-3507
pubmed: 29680933
Psychiatry J. 2014;2014:692423
pubmed: 24839597
AIDS Care. 2011 Sep;23(9):1102-10
pubmed: 21476149
Drug Alcohol Depend. 2003 May 1;70(1):1-10
pubmed: 12681520
J Soc Social Work Res. 2012 Mar 23;3(2):65-79
pubmed: 22639705
J Subst Abuse Treat. 2018 Oct;93:31-37
pubmed: 30126539
Addiction. 2008 Mar;103(3):387-96
pubmed: 18269361
Addiction. 2002 Jun;97(6):677-89
pubmed: 12084137
Alcohol Clin Exp Res. 2001 May;25(5):711-6
pubmed: 11371720
J Subst Abuse Treat. 2012 Jan;42(1):35-44
pubmed: 21940134
J Psychoactive Drugs. 1990 Apr-Jun;22(2):197-209
pubmed: 2197394
J Health Soc Behav. 1979 Jun;20(2):108-19
pubmed: 479524
J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S182-90
pubmed: 25978486
Am J Psychiatry. 2012 Jan;169(1):64-70
pubmed: 21955932
Arch Gen Psychiatry. 2009 Jul;66(7):785-95
pubmed: 19581570
J Subst Abuse Treat. 2009 Apr;36(3):321-30
pubmed: 18835677
Subst Use Misuse. 2019;54(9):1461-1474
pubmed: 31030611
Drug Alcohol Depend. 2010 Dec 1;112(3):194-200
pubmed: 20667666
Am J Addict. 2011 Nov-Dec;20(6):555-62
pubmed: 21999502
Drug Alcohol Depend. 2008 Jan 11;93(1-2):21-9
pubmed: 17980512
Addiction. 2007 Nov;102(11):1730-9
pubmed: 17935581
Soc Sci Med. 1999 May;48(9):1123-33
pubmed: 10220014
J Stud Alcohol Drugs. 2012 Mar;73(2):216-25
pubmed: 22333329
J Subst Abuse Treat. 2020 Sep;116:108044
pubmed: 32741497
J Subst Abuse Treat. 2016 Mar;62:55-61
pubmed: 26712040
Drug Alcohol Depend. 1996 Dec 2;43(1-2):79-86
pubmed: 8957146
Subst Abus. 2015;36(2):183-91
pubmed: 25839214
JMIR Public Health Surveill. 2018 Jan 19;4(1):e12
pubmed: 29351899
J Am Acad Child Adolesc Psychiatry. 2001 Mar;40(3):274-81
pubmed: 11288768

Auteurs

Oluwaseun Falade-Nwulia (O)

Johns Hopkins University School of Medicine, Baltimore, MD, United States of America. Electronic address: ofalade1@jhmi.edu.

Marisa Felsher (M)

Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.

Michael Kidorf (M)

Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.

Karin Tobin (K)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.

Cui Yang (C)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.

Carl Latkin (C)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH